JP2926273B2 - ホスホン酸ジエステル誘導体 - Google Patents

ホスホン酸ジエステル誘導体

Info

Publication number
JP2926273B2
JP2926273B2 JP6517889A JP51788994A JP2926273B2 JP 2926273 B2 JP2926273 B2 JP 2926273B2 JP 6517889 A JP6517889 A JP 6517889A JP 51788994 A JP51788994 A JP 51788994A JP 2926273 B2 JP2926273 B2 JP 2926273B2
Authority
JP
Japan
Prior art keywords
group
lower alkyl
alkyl group
diethyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP6517889A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO1994018212A1 (ja
Inventor
恭生 小路
可彦 津田
一彦 堤
泰秀 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OOTSUKA SEIYAKU KOJO KK
Original Assignee
OOTSUKA SEIYAKU KOJO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OOTSUKA SEIYAKU KOJO KK filed Critical OOTSUKA SEIYAKU KOJO KK
Priority to JP6517889A priority Critical patent/JP2926273B2/ja
Publication of JPWO1994018212A1 publication Critical patent/JPWO1994018212A1/ja
Application granted granted Critical
Publication of JP2926273B2 publication Critical patent/JP2926273B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6517889A 1993-02-15 1994-02-10 ホスホン酸ジエステル誘導体 Expired - Fee Related JP2926273B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6517889A JP2926273B2 (ja) 1993-02-15 1994-02-10 ホスホン酸ジエステル誘導体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2573293 1993-02-15
JP5-25732 1993-02-15
PCT/JP1994/000209 WO1994018212A1 (en) 1993-02-15 1994-02-10 Phosphonic diester derivative
JP6517889A JP2926273B2 (ja) 1993-02-15 1994-02-10 ホスホン酸ジエステル誘導体

Publications (2)

Publication Number Publication Date
JPWO1994018212A1 JPWO1994018212A1 (ja) 1995-04-06
JP2926273B2 true JP2926273B2 (ja) 1999-07-28

Family

ID=12173991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6517889A Expired - Fee Related JP2926273B2 (ja) 1993-02-15 1994-02-10 ホスホン酸ジエステル誘導体

Country Status (13)

Country Link
US (1) US5480874A (enExample)
EP (1) EP0638581B1 (enExample)
JP (1) JP2926273B2 (enExample)
KR (1) KR100296163B1 (enExample)
CN (1) CN1046733C (enExample)
AT (1) ATE174923T1 (enExample)
AU (1) AU660125B2 (enExample)
CA (1) CA2118007C (enExample)
DE (1) DE69415436T2 (enExample)
DK (1) DK0638581T3 (enExample)
ES (1) ES2126097T3 (enExample)
TW (1) TW260664B (enExample)
WO (1) WO1994018212A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3500468B2 (ja) * 1995-12-27 2004-02-23 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US6284748B1 (en) * 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
EP0970095B1 (en) * 1997-03-07 2003-10-29 Metabasis Therapeutics, Inc. Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
ATE361917T1 (de) 1999-04-22 2007-06-15 Lundbeck & Co As H Selektive npy(y5)-antagonisten
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
WO2003030902A1 (en) 2001-10-09 2003-04-17 Tularik Inc. Imidazole derivates as anti-inflammatory agents
US20050065118A1 (en) * 2001-10-16 2005-03-24 Jing Wang Organosulfur inhibitors of tyrosine phosphatases
EP1583530A4 (en) 2002-01-16 2008-07-23 Univ Virginia 2-AMINOTHIAZOLE ALLOSTERIC AMPLIFIERS OF A1 ADENOSINE RECEPTORS
EP1765332A2 (en) * 2004-06-17 2007-03-28 Cengent Therapeutics, Inc. Trisubstituted nitrogen modulators of tyrosine phosphatases
US20060135483A1 (en) * 2004-07-09 2006-06-22 Cheruvallath Zacharia S Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
NZ552650A (en) * 2004-08-05 2010-09-30 Hoffmann La Roche Substituted N-acyl-2-aminothiazoles
WO2006028970A1 (en) * 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
AU2005293607A1 (en) * 2004-10-07 2006-04-20 Boehringer Ingelheim International Gmbh PI3 kinases
TW200722432A (en) * 2005-03-25 2007-06-16 Sankyo Co Thiazole compounds
EP1882694B1 (en) * 2005-05-19 2013-04-03 Nissan Chemical Industries, Ltd. Oligomers and polymers of thiophene compounds having phosphoric ester and process for producing the same
US8779154B2 (en) * 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) * 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
CN114681454B (zh) * 2022-03-17 2024-05-07 江南大学 噻唑类化合物在制备抗sars-cov-2新型冠状病毒药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
US4434162A (en) * 1981-02-17 1984-02-28 Kanebo, Ltd. Phosphonic acid ester, pharmaceutical compositions containing the same and method of using the same
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
JPH0745508B2 (ja) * 1988-06-29 1995-05-17 株式会社大塚製薬工場 カルボン酸アミド誘導体
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
ES2140456T3 (es) * 1992-05-21 2000-03-01 Otsuka Pharma Co Ltd Derivado de diester fosfonico.

Also Published As

Publication number Publication date
DE69415436D1 (de) 1999-02-04
CA2118007C (en) 2003-12-02
EP0638581B1 (en) 1998-12-23
CN1046733C (zh) 1999-11-24
US5480874A (en) 1996-01-02
CA2118007A1 (en) 1994-08-18
DE69415436T2 (de) 1999-06-02
WO1994018212A1 (en) 1994-08-18
EP0638581A1 (en) 1995-02-15
EP0638581A4 (en) 1995-04-12
AU660125B2 (en) 1995-06-08
KR950700917A (ko) 1995-02-20
TW260664B (enExample) 1995-10-21
ATE174923T1 (de) 1999-01-15
KR100296163B1 (ko) 2001-11-05
ES2126097T3 (es) 1999-03-16
DK0638581T3 (da) 1999-08-23
CN1102528A (zh) 1995-05-10
AU6010794A (en) 1994-08-29

Similar Documents

Publication Publication Date Title
JP2926273B2 (ja) ホスホン酸ジエステル誘導体
JP2759228B2 (ja) ホスホン酸ジエステル誘導体
JPWO1994018212A1 (ja) ホスホン酸ジエステル誘導体
JP3500468B2 (ja) ホスホン酸ジエステル誘導体
JPWO1993023409A1 (ja) ホスホン酸ジエステル誘導体
KR100297623B1 (ko) 포스폰산디에스테르유도체
JP3972163B2 (ja) ホスホン酸ジエステル誘導体
JP4032193B2 (ja) ホスホン酸ジエステル誘導体
JP3972167B2 (ja) ホスホン酸ジエステル誘導体
JP2926274B2 (ja) ホスホン酸ジエステル誘導体
KR100305959B1 (ko) 포스폰산디에스테르유도체
JPH0745508B2 (ja) カルボン酸アミド誘導体
EP0185132B1 (en) Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
JP3785514B2 (ja) ホスホン酸ジエステル誘導体
JP3533542B2 (ja) ホスホン酸ジエステル誘導体
JPWO1995006051A1 (ja) ホスホン酸ジエステル誘導体
JPH10298189A (ja) クロム錯体
JPS62289588A (ja) 新規なトリオ−ル誘導体、その製造方法及びその誘導体を含有する血圧降下剤
JPS61236789A (ja) 新規ベンジルホスフイン酸エステル誘導体、その製造法およびそれを有効成分とする医薬組成物

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110514

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees